Yes. 19 FDA-approved labels for Isotretinoin carry a boxed warning, and its subject is embryo-fetal toxicity, contraindicated in pregnancy. A boxed warning is the most serious warning the FDA requires on a prescription label. It is applied to the drug and to the situations in which it is used, not to any particular person taking it.
What the warning says
Below is how the Isotretinoin warning opens on one specific label, identified underneath it. Of the 19 Isotretinoin labels sampled, 13 carried materially different wordings and this was the most common, used by 4 of them.
WARNING: EMBRYO-FETAL TOXICITY – CONTRAINDICATED IN PREGNANCY Isotretinoin capsules can cause severe life-threatening birth defects and is contraindicated in pregnancy. There is an extremely high risk that life-threatening birth defects will result if pregnancy occurs while taking any amount of isotretinoin capsules even for short periods of time. Potentially any fetus exposed during pregnancy can be affected. There are no accurate means of determining prenatally whether an exposed fetus has been affected.
ISOTRETINOIN, Upsher-Smith Laboratories, LLC, label version effective 13 February 2026. Opening of the warning; read the full label on DailyMed.Why the wording differs between manufacturers
There is no single official text of a boxed warning. The FDA sets what a warning must cover, and each manufacturer writes its own label within that. Of the 19 Isotretinoin labels sampled for this page, 13 carried materially different wordings of the same warning, and the version quoted above was used by 4 of them.
The hazard does not change between those 13 versions. Only the sentences do, which is why a refill from a different manufacturer can carry warning text that reads differently without anything about Isotretinoin or its risks having changed.
Isotretinoin is dispensed under 19 current FDA labels despite this warning, which is the point worth holding onto: a boxed warning is a disclosure requirement, not a verdict. What a boxed warning does and does not mean sets out the distinction.
Common questions
Does Isotretinoin have a black box warning?
Yes. 19 FDA-approved labels for Isotretinoin carry a boxed warning, and its subject is embryo-fetal toxicity, contraindicated in pregnancy. A boxed warning is the strongest warning the FDA requires on a prescription label, and it is applied to the drug, not to any individual taking it.
What does the Isotretinoin boxed warning say?
The wording is set by each manufacturer within FDA requirements, so it varies. In the version quoted on this page, taken from a label effective 13 February 2026, the warning concerns embryo-fetal toxicity, contraindicated in pregnancy. The full text is linked so the exact version can be read rather than summarised.
Does the Isotretinoin boxed warning mean the drug is unsafe or being withdrawn?
No. It means the FDA requires the risk of embryo-fetal toxicity, contraindicated in pregnancy to be communicated prominently so prescribers weigh it explicitly. Isotretinoin remains FDA-approved and is dispensed under 19 current labels. A boxed warning is a disclosure requirement, not a judgement that a drug should not be used.
Why do different pharmacies show different warning text for the same drug?
Because each manufacturer writes its own label within the FDA's requirements. Of 19 Isotretinoin labels sampled here, 13 carried materially different wordings of the same warning. The hazard described is the same; the sentences are not. This is a common source of confusion when a prescription is refilled with a different manufacturer's product.
Should I stop taking Isotretinoin because of this warning?
This page does not answer that and cannot. The warning about embryo-fetal toxicity, contraindicated in pregnancy is written for a prescriber deciding whether Isotretinoin suits a particular patient, and stopping a prescribed medicine carries its own risks that this page knows nothing about. Raise it with the prescriber or a pharmacist, who can see the whole picture.
Where this page's information comes from
The quotation above is from one Isotretinoin label, linked below by its DailyMed set identifier so the exact version can be opened rather than taken on trust. The figure of 19 labels, and the count of 13 distinct wordings among 19 sampled, were computed from the openFDA labelling API on 30 August 2026.
- ISOTRETINOIN prescribing information, Upsher-Smith Laboratories, LLC, effective 13 February 2026.
- openFDA drug labelling API, the source of the label counts and variant counts on this page.
Labels are revised over time. The version linked above is the one this page was written against, and a newer revision may differ. Counts reflect the labels present in openFDA on the retrieval date.